Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
28m
on MSN
Why Pfizer Will Find It Hard to Appease Its Activist Investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Mexican mayor assassinated
Tickets to climb to $5
Milton becomes Category 5
Musk's X appeal rejected
American sentenced in RU
Ranger dies during rescue
Vanderbilt, Arkansas fined
Richest female musician
Human life expectancy study
Grammy-winning singer dies
Supreme Court rejects bid
King named grand marshal
Ordered to open app store
North Dakota wildfires
NC voting rule changes
Record military aid to Israel
GA abortion ban reinstated
US antitrust case advances
Targeted by a cyberattack
TX emergency abortion case
R. Kelly's appeal declined
Ukraine strikes RU oil hub
US overdose deaths drop
Hamas strikes Tel Aviv
Another top aide resigns
Faces assault, drug charges
Names new school board
Launches asteroid probe
Hamas backers sanctioned
IVF clinic's appeal rejected
Related topics
COVID
Pfizer
GSK
Respiratory Syncytial Virus
United States
Feedback